Gabapentin is one of the most commonly prescribed medications for neuropathic pain, and major neurology guidelines recommend it as a first-line treatment. Its only FDA-approved pain indication is postherpetic neuralgia (the nerve pain that lingers after shingles), but doctors prescribe it off-label for many other types of nerve pain, including diabetic neuropathy, sciatica-related nerve irritation, and chemotherapy-induced neuropathy. How well it works, though, is more modest than many people expect.
What Gabapentin Is Approved For
The FDA approved gabapentin (brand name Neurontin) for two conditions: postherpetic neuralgia in adults and as an add-on therapy for partial seizures. That means when your doctor prescribes it for diabetic neuropathy, fibromyalgia, or other nerve pain conditions, they’re using it off-label. This is extremely common and well-supported by clinical evidence, but it’s worth knowing the distinction because insurance coverage can sometimes vary.
The American Academy of Neurology’s updated guidelines for painful diabetic neuropathy give gabapentin (and its cousin pregabalin, grouped together as “gabapentinoids”) a Level B recommendation, meaning clinicians “should offer” them alongside other first-line options like certain antidepressants. It sits in the same tier as the most commonly used nerve pain medications.
How It Reduces Nerve Pain
Despite its name, gabapentin doesn’t actually work on the GABA system in any meaningful way. Instead, it attaches to a specific part of calcium channels on nerve cells. These channels control how much calcium flows into the nerve ending, which in turn controls how many pain signals get released. By binding to these channels, gabapentin reduces the recycling of calcium channels back to the nerve surface, so fewer channels are available and fewer pain signals get transmitted.
There’s also a second, separate effect. Gabapentin appears to block the formation of new excitatory connections between nerves, a process that can go haywire in chronic pain states and amplify pain signals beyond what’s appropriate. This dual action helps explain why gabapentin can be useful for the burning, shooting, or electric-shock sensations characteristic of neuropathy.
How Well It Actually Works
Gabapentin’s pain relief is real but moderate. Across nine clinical trials with nearly 2,000 patients, gabapentin reduced pain scores by less than 1 point on a 0-to-10 scale compared to placebo. That’s a meaningful difference for some people, but it’s not dramatic.
A more telling number: about 31% of patients on gabapentin achieved at least a 50% reduction in their pain, compared to 18% on placebo. That 13-percentage-point difference translates to a “number needed to treat” of about 8, meaning you’d need to treat 8 patients before one of them experiences substantial relief that wouldn’t have happened with a sugar pill. Put another way, roughly 15% of patients are true responders who get significant benefit specifically from gabapentin. For those people, the effect can be life-changing. For the majority, it provides partial relief at best.
This doesn’t mean gabapentin is a poor choice. Neuropathic pain is notoriously difficult to treat, and most medications in this space have similarly modest average effects. The challenge is that there’s no reliable way to predict who will respond well, so trying it for several weeks is often the only way to know.
Gabapentin vs. Pregabalin
Pregabalin (Lyrica) is gabapentin’s newer relative, and a large meta-analysis of nine studies with over 1,800 participants found pregabalin produced modestly better pain relief on visual pain scales. The difference emerged by about four weeks and persisted through 12 to 14 weeks of treatment. At the two-week mark, the two drugs performed about equally.
Side effects were similar overall between the two medications, with one notable exception: gabapentin caused significantly more nausea and vomiting than pregabalin across studies. If you’ve tried gabapentin and found the stomach-related side effects intolerable, pregabalin may be easier to manage. However, pregabalin is a controlled substance (Schedule V) while gabapentin is not federally scheduled in most states, which can affect prescribing and refill logistics.
Common Side Effects
The most frequent side effects are neurological. In clinical trials, about 20% of patients experienced drowsiness, 18% had dizziness, 13% had trouble with coordination, and 11% reported fatigue. These effects are most pronounced when you first start the medication or increase your dose, and they tend to improve over the first couple of weeks as your body adjusts.
Because gabapentin can cause significant drowsiness, the typical approach is to take the first dose in the evening. This lets you sleep through the worst of the sedation and can actually be a benefit if nerve pain has been disrupting your sleep. The drowsiness and dizziness also mean you should be cautious about driving or operating machinery until you know how the medication affects you.
Starting Dose and What to Expect
Gabapentin is almost always started low and increased gradually. A typical starting point is 300 mg once daily (taken at bedtime), then increasing to 300 mg two or three times daily over the first week or so. From there, your doctor will continue increasing the dose based on your response and tolerance. For general neuropathic pain, the effective range is usually 300 to 1,200 mg three times daily, with a maximum of 3,600 mg per day. For postherpetic neuralgia specifically, the ceiling is typically 1,800 mg per day.
This slow ramp-up means you shouldn’t expect full results right away. Most clinical trials assessed outcomes at 4 to 12 weeks, and meaningful differences from placebo often don’t emerge until the dose has been optimized over several weeks. If you’ve been on a low dose for a week and feel nothing, that’s expected. The titration process requires patience, and many people need to reach the higher end of the dosing range before they notice a significant change.
Stopping Gabapentin Safely
One important thing to know: you should not stop gabapentin abruptly after taking it regularly. Withdrawal symptoms can appear within one to two days of stopping and may include anxiety, insomnia, nausea, sweating, and in rare cases, more severe symptoms resembling alcohol or benzodiazepine withdrawal, including confusion, rapid heart rate, and elevated blood pressure. Case reports have documented severe mental status changes appearing up to 10 days after discontinuation, even in patients who were being tapered.
The recommended approach is a gradual taper over weeks, similar to how benzodiazepines are tapered. If you and your doctor decide gabapentin isn’t working for you, plan for a slow step-down rather than simply stopping your prescription.
Who Benefits Most
Gabapentin tends to work best for the types of neuropathic pain characterized by burning, tingling, shooting, or electric sensations. It’s less effective for the dull, aching component of pain that sometimes accompanies neuropathy. People with postherpetic neuralgia have the strongest evidence behind them, since that’s the condition gabapentin was specifically tested and approved for. Diabetic neuropathy also has substantial supporting data, and it’s one of the most common reasons gabapentin is prescribed.
If you have kidney problems, gabapentin requires dose adjustments because the drug is eliminated almost entirely through the kidneys. Reduced kidney function means the drug stays in your system longer, increasing the risk of side effects at standard doses. Your doctor will likely check your kidney function before prescribing and adjust accordingly.
For the roughly 15% of neuropathy patients who respond well, gabapentin can meaningfully reduce pain and improve sleep and daily function. For others, it may provide only partial relief and work better as one piece of a broader pain management approach that includes other medications, physical therapy, or lifestyle modifications.